Evidence map›Paper›PMID 27393540›Full record

Trial reportThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2016

Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.

E R Maritz, G Montepiedra, L Liu, C D Mitchell, S A Madhi, R Bobat, A Violari, A Ogwu, A C Hesseling, M F Cotton

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Predictors of TB disease in HIV-exposed children from Southern Africa.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Trial
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

E R MaritzChildren's Infectious Diseases Clinical Research Unit, Department of Paediatrics & Child Health, Stellenbosch University, Cape Town, South Africa; Swiss Children's Hospital, Liestal, Switzerland.
G MontepiedraCenter for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, USA.
L LiuCenter for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, USA.
C D MitchellLeonard M Miller School of Medicine, University of Miami, Miami, Florida, USA; Respiratory and Meningeal Pathogens Research Unit, Medical Research Council, and Department of Science & Technology, National Research Foundation, University of the Witwatersrand, Johannesburg, South Africa.
S A MadhiDepartment of Paediatrics, University of KwaZulu-Natal, Durban, South Africa.
R BobatPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
A ViolariBotswana-Harvard School of Public Health AIDS Institute, Gaborone, Botswana.
A OgwuBotswana-Harvard School of Public Health AIDS Institute, Gaborone, Botswana.
A C HesselingDepartment of Paediatrics & Child Health, Desmond Tutu TB Centre, Stellenbosch University, Cape Town, South Africa.
M F CottonChildren's Infectious Diseases Clinical Research Unit, Department of Paediatrics & Child Health, Stellenbosch University, Cape Town, South Africa.
Cancer Research And Biostatistics · USUniversity of KwaZulu-Natal · ZAUniversity of the Witwatersrand · ZA

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Sharon A Nachman · 2011 to 2026
$278.1M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
Soweto Clinical Trials UnitUM1AI069453 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI Glenda E Gray, Lerato Mohapi · 2012 to 2026
$40.9M
Stellenbosch University Clinical Trial Unit, Cape Town, South AfricaUM1AI069521 · NIAID · STELLENBOSCH UNIVERSITY · PI Shaun Barnabas, Anneke Catharina Hesseling · 2012 to 2026
$21.5M
NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI069453NIAID NIH HHS UM1 AI069521NIAID NIH HHS UM1 AI106716
6 · The paper itself

Abstract

backgroundIdentifying source cases of children exposed to tuberculosis (TB) is challenging. We examined the time-point of obtaining contact information of TB source cases in human immunodeficiency virus (HIV) infected and HIV-exposed uninfected (HEU) children in a randomised, placebo-controlled trial of pre-exposure to isoniazid prophylaxis.

methodsA total of 543 HIV-infected and 808 HEU infants without TB exposure aged 3-4 months were enrolled between 2004 and 2008. At 3-monthly follow-up, infants were evaluated for TB and care givers were asked about new TB exposure.

resultsIn total, 128 cases of TB disease and 40 deaths were recorded among 19% (105/543) of the HIV-infected and 8% (63/808) of the HEU children; 229 TB contact occasions were reported in 205/1351 (15%) children, of which 83% (189/229) were in the household. Of the 189 household contacts, 108 (53%) underwent microbiological evaluations; 81% (87/108) were positive. HIV-infected and HEU infants had similar frequencies of TB contact: in 48% of infants with definite TB, 58% with probable TB and 43% with possible TB. Of 128 children diagnosed with TB, a TB contact was identified for 59. Of these, 29/59 (49%) were identified at or after the child's TB diagnosis.

conclusionTB source cases are often identified at or after a child's TB diagnosis. More effort is required for earlier detection.

Indexed as

CoinfectionPrimary PreventionAge FactorsAntitubercular AgentsEarly DiagnosisFemaleHIV InfectionsHumansInfantIsoniazidMalePrevalenceRisk FactorsSouth AfricaTime FactorsTreatment OutcomeAntitubercular AgentsIsoniazid

Identifiers

PMID27393540
PMCPMC5066391
OpenAlexW2466230014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.